Analysis of the Potentially Parasitocidal Effect of a Long Term Chemotherapy With Benzimidazoles
NCT00658294 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 34
Last updated 2017-10-17
Summary
The aim of this study is to evaluate PET-CT and EmII/3-10 serology as potential markers to assess the parasitocidal effect of benzimidazoles
* Trial with medicinal product
Conditions
- Alveolar Echinococcosis
Interventions
- OTHER
-
Stop treatment
Sponsors & Collaborators
-
University of Zurich
lead OTHER
Principal Investigators
-
Beat Müllhaupt 01 Studienregister MasterAdmins · UniversitaetsSpital Zuerich
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2008-01-31
- Primary Completion
- 2012-12-31
- Completion
- 2012-12-31
Countries
- Switzerland
Study Locations
More Related Trials
-
O6-benzylguanine and Carmustine in Treating Patients With Unresectable Locally Recurrent or Metastatic Melanoma
NCT00005961 ·Status: COMPLETED ·Phase: PHASE2
-
Dacarbazine and Carmustine in Metastatic Melanoma
NCT01692691 ·Status: TERMINATED ·Phase: PHASE2
-
Merkel Positron Emission Tomography (PET) Protocol
NCT01013779 ·Status: COMPLETED ·Phase: PHASE2
-
Intralesional PV-10 Chemoablation of Metastatic Melanoma
NCT00219843 ·Status: COMPLETED ·Phase: PHASE1
-
Pilot Study Investigating the Metabolic Activity and Transcriptional Profiling in Vivo in Tumor Biopsies in Melanoma Patients During Treatment With Pazopanib Alone and in Combination With Paclitaxel
NCT01666418 ·Status: COMPLETED ·Phase: PHASE2
-
A Phase II Trial of PD-L1 Therapy Combined With Anti-VEGF Therapy in Unresectable or Metastatic Melanoma
NCT04356729 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Safety Study of Combined Chemotherapy and Endostar to Untreated Patients With Advanced Melanoma
NCT00813449 ·Status: UNKNOWN ·Phase: PHASE2
-
A-dmDT390-bisFv(UCHT1) Fusion Protein With Ionizing Radiation and Pembrolizumab for the Treatment of Stage IV Melanoma
NCT02990416 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
O6-Benzylguanine and Topical Carmustine in Treating Patients With Early-Stage IA-IIA Cutaneous T-Cell Lymphoma
NCT00961220 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Interleukin-2 With or Without Histamine Dihydrochloride in Treating Patients With Stage IV Melanoma Metastatic to the Liver
NCT00039234 ·Status: UNKNOWN ·Phase: PHASE3
-
Evaluation of Efficacy of Photodynamic Therapy in Basal Cell Carcinoma
NCT00985829 ·Status: COMPLETED ·Phase: PHASE1
-
Electrochemotherapy Changes in Tumor Microenvironment of Cutaneous and Subcutaneous Metastases in Melanoma Patients
NCT06388252 ·Status: ENROLLING_BY_INVITATION ·Phase: NA
-
Intratumoral Injection Of Alpha-Gal Glycosphingolipids
NCT00668512 ·Status: COMPLETED ·Phase: PHASE1
-
Combination Chemotherapy, Interferon Alfa, and Interleukin-2 in Treating Patients With Metastatic Melanoma
NCT00002669 ·Status: COMPLETED ·Phase: PHASE2
-
Atezolizumab in Combination With Bevacizumab in Patients With Unresectable Locally Advanced or Metastatic Mucosal Melanoma
NCT04091217 ·Status: COMPLETED ·Phase: PHASE2
-
Temozolomide or Selumetinib in Treating Patients With Metastatic Melanoma of the Eye
NCT01143402 ·Status: COMPLETED ·Phase: PHASE2
-
Phase 2 Study of Intralesional PV-10 for Metastatic Melanoma
NCT00521053 ·Status: COMPLETED ·Phase: PHASE2
-
ECT-Pembrolizumab in Patients With Unresectable Melanoma With Superficial or Superficial and Visceral Metastases
NCT03448666 ·Status: WITHDRAWN ·Phase: PHASE2
-
PS-341 in Treating Patients With Metastatic Malignant Melanoma
NCT00024011 ·Status: COMPLETED ·Phase: PHASE2
-
Platin-based Chemotherapeutics to Enhance Dendritic Cell Vaccine Efficacy in Melanoma Patients
NCT02285413 ·Status: COMPLETED ·Phase: PHASE2
-
Immuno-monitoring of Patients With Metastatic Melanoma (AJCC Stadium IV) Under Chemotherapy
NCT02332642 ·Status: COMPLETED
-
Use of Jet-injection in Photodynamic Therapy for Basal Cell Carcinoma
NCT04552990 ·Status: COMPLETED ·Phase: PHASE2
-
Phase I/II Study of Chemo-Immunotherapy Combination in Melanoma Patients
NCT00559026 ·Status: COMPLETED ·Phase: PHASE1
-
Monocentric Pilot Study Investigating the Metabolic Activity of Melanoma in Vivo During Sorafenib and Dacarbazine
NCT00794235 ·Status: COMPLETED ·Phase: PHASE2
-
Use of 852A in Metastatic Cutaneous Melanoma.
NCT00189332 ·Status: COMPLETED ·Phase: PHASE2